Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato Gel 0.05% in Subjects With Actinic Keratosis

ClinicalTrials.gov ID: NCT02654769

Public ClinicalTrials.gov record NCT02654769. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 5:19 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Multicenter Randomized Double-Blind Vehicle-Controlled Parallel Group Study to Determine the Therapeutic Equivalence of Generic Ingenol Mebutate Gel 0.05% and Picato® Gel 0.05% in Subjects With Actinic Keratosis on the Trunk or Extremities

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this study was to evaluate the safety and therapeutic equivalence of generic ingenol mebutate gel, 0.05% to Picato gel, 0.05% and to establish the superiority of the efficacy of these two products over the vehicle gel in the treatment of Actinic Keratosis (AK) on the trunk or extremities.

Study identification

NCT ID
NCT02654769
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Actavis Inc.
Industry
Enrollment
441 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 95 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2015
Primary completion
Aug 31, 2015
Completion
Aug 31, 2015
Last update posted
May 11, 2020

2015

United States locations

U.S. sites
22
U.S. states
13
U.S. cities
22
Facility City State ZIP Site status
Center for Dermatology Clinical Research, Inc Fremont California 94538
SD Sports Medicine & Family Health Center San Diego California 92120
The Center for Clinical and Cosmetic Research Aventura Florida 33180
Savin Medical Group Research Center Miami Lakes Florida 33014
Tory P. Sullivan, M.D., P.A. North Miami Beach Florida 33162
Moore Clinical Research, Inc. Tampa Florida 33609
Northwest Clinical Trials, Inc. Boise Idaho 83704
Altman Dermatology Associates Arlington Heights Illinois 60005
Christie Clinic, LLC Champaign Illinois 61820
Shideler Clinical Research Center Carmel Indiana 46032
Dawes Fretzin Clinical Research Group, LLC Indianapolis Indiana 46256
The Indiana Clinical Trials Center Plainfield Indiana 46168
Bettencourt Skin Center Henderson Nevada 89074
Union Square Dermatology New York New York 10003
Dermatology Consulting Services High Point North Carolina 27262
PMG Research of Winston-Salem, LLC Winston-Salem North Carolina 27103
Omega Medical Research, 400 Bald Hill Road, Warwick, RI 02886 Warwick Rhode Island 02886
Greenville Dermatology, LLC Greenville South Carolina 29607
Dermatology Associates of Knoxville, PC Knoxville Tennessee 37917
DermResearch, Inc.Austin Austin Texas 78759
The Center for Skin Research Houston Texas 77056
Virginia Clinical Research Norfolk Virginia 23507

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02654769, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 11, 2020 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02654769 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →